Project Details
Description
Phase 2, Parallel???Arm Study of MGCD265 in Patients with Locally Advanced or Metastatic Non???Small Cell Lung Cancer with Activating Genetic Alterations in Mesenchymal???Epithelial Transition Factor
| Status | Finished |
|---|---|
| Effective start/end date | 9/1/15 → 3/14/18 |
Funding
- MIRATI THERAPEUTICS, INC.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.